Research in China
November 16, 2011
Beijing Tiantan Biological Products (600161.SH) plans to sign financial aid, loan and unilateral guarantee agreements with the Bill & Melinda Gates Foundation to develop oral polio vaccines (OPV), reports stcn.com, citing a company filing.